FINAL WEEK to apply for more than $1 million in award funding! Let us fund your CGT research; apply through Aug. 1.
February 23, 2022 | 1:00-3:00 p.m. (CT)
This session highlights the ongoing research related to the administration of high-dose adeno-associated virus (AAV) in patients with an emphasis on safety and tolerability findings. Speakers will provide a better understanding of the responses of patients to systemic delivery of AAV and the array of related factors.
Registrants & ASGCT Members: Watch On Demand
Juliette Hordeaux, DVM, PhD University of Pennsylvania
Lee Sweeney, PhD University of Florida
Louise Rodino-Klapac, PhD Sarepta Therapeutics
Serge Braun, PharmD, PhD AFM-Telethon
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico